Coherus BioSciences (CHRS) Competitor Comparison
We are evaluating the key criteria listed to compare Coherus BioSciences (CHRS) against its competitors in the Biotechnology industry.
Market Capitalization
204 / 368Gross Profits
206 / 278Total Revenue
59 / 300EBITDA
245 / 337Free Cashflow
315 / 352Quick Ratio
311 / 357Earnings per Share
69 / 359Dividend yield
0 / 6Total Cash
196 / 358Performance 3 years
335 / 368Performance 5 years
329 / 368Performance 10 years
274 / 368Linearity 3 years
228 / 368Linearity 5 years
215 / 368Linearity 10 years
123 / 368Total Rank
90 / 368Dividend Rank
93 / 368Valuation Rank
161 / 368Piotroski Rank
269 / 368Muliplier Rank
94 / 368Gross Profits - CHRS ranking 206 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.